According to reporting from Reuters, reviewers at the agency pointed to an inability to differentiate from placebo to justify rejecting the drug, but an FDA office director approved the drug anyway.
A review of the J-20 “Mighty Dragon’s” origin reveals its rapid development as a direct response to the U.S. F-22. -The ...
Despite being plagued by a rash of disasters and safety concerns over the past several years, Boeing was awarded the F-47 ...
An internal Air Force memo from the outgoing commander of Global Strike Command, Gen. Thomas Bussiere, recommends the B-21 ...
EADaily, November 7th, 2025. China has reset the American military technology of Stealth stealth aircraft. Robert Frantsev, ...
A second J-36 airframe has emerged with significant changes to its inlets, gear, and exhaust, offering clues to its state of development.
THIS is the chilling moment China brandishes its new J-36 stealth jet in a public show of force to intimidate the West. The ...
Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into ...
Attracts funding from Preeminent VCs, CyberArk Executive Chair * Introduces paradigm shift in CISO mindset from reactive to predictive intelligenc ...